TERT and neoplasm: More recently, a preclinical study evaluating the co-administration of TERT vaccine with immune checkpoint blockade (anti-CTLA-4) has revealed that a synergistic effect could be achieved, resulting in suppression of tumor growth accompanied by increased survival (Table 1) [148].